99 signals · alpha_vantage, bluesky, newsapi +1 more
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Some stress signals present but below significant thresholds.
Low risk signals — no significant operational or reputational pressure detected.
Auto-generated from public signals — AI summary pending. Based on 3 recent signals.
Berkshire Hathaway Sells $69M of DaVita Stock Amid HHS Kidney Reforms, Securities Fraud Probe International Business Times UK
Warren Buffett's Berkshire Hathaway sold $69M in DaVita shares as the kidney-care giant faces growing regulatory scrutiny and a securities fraud investigation. Is this a warning investors shouldn't ignore? Read: www.ibtimes.co.uk/berkshire-ha... #WarrenBuffett #Stocks #Investing #WallStreet
Warren Buffett's Berkshire Hathaway sold $69M in DaVita shares as the kidney-care giant faces growing regulatory scrutiny and a securities fraud investigation.
Diversified conglomerate with insurance and investment holdings.
Based on 99 signals across 4 sources · snapshot 4 Nov 2026
Strong: enough recent evidence to trust this score.
Overall community sentiment for Berkshire Hathaway is positive based on public signals as of 4 Nov 2026.
Based on 99 signals across 4 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
Every direct to consumer medical site should either be (1) illegal or (2) required to look like a cross between a class action settlement website and Berkshire Hathaway